Depression

Opinion: New party drug derivative has the potential to treat depression

Opinion: New party drug derivative has the potential to treat depression

Last week, the Food and Drug Administration (FDA) approved the use of a new antidepressant, esketamine, which has the potential to reduce depressive symptoms mere hours after administration. While this may sound like a near-miraculous treatment, the administration of esketamine is controversial.